Professor A. John Camm is an internationally recognized clinical cardiologist who has established himself as a preeminent authority in cardiac electrophysiology and rhythm disorders. He has served as Professor of Clinical Cardiology at St George's University of London since 1986, following his medical training at Guy's Hospital Medical School in London where he began his studies in 1971. After completing his training, he spent a year conducting research in Vermont, USA, before advancing through the academic ranks at St Bartholomew's Hospital, where he progressed from Junior to Wellcome Senior Lecturer in 1979 and ultimately to Sir Ronald Bodley Scott Professor of Cardiovascular Medicine in 1983. His distinguished career has been marked by significant leadership positions across major cardiac institutions and professional societies throughout his decades-long contribution to cardiovascular medicine.
Professor Camm's scholarly contributions have profoundly shaped contemporary approaches to cardiac arrhythmias, with particular emphasis on atrial fibrillation, ventricular tachycardia, and sudden cardiac death. His extensive research portfolio includes more than 1,300 publications in peer-reviewed journals and over 500 book chapters that have established foundational knowledge in cardiac electrophysiology and therapeutic interventions. His clinical investigations into antiarrhythmic drugs demonstrated significant reductions in hospitalization frequency and cardiovascular mortality for patients with atrial fibrillation, representing a major advancement in treatment protocols. These contributions have directly influenced clinical guidelines worldwide and established new standards for managing complex cardiac rhythm disorders through evidence-based therapeutic approaches.
As a thought leader in cardiovascular medicine, Professor Camm has served in numerous influential positions including President of the Arrhythmia Alliance and President-Elect of the European Heart Rhythm Association, significantly shaping the global discourse on cardiac rhythm management. He currently serves as Editor-in-Chief of EP-Europace and Clinical Cardiology, and as an Editor for the European Heart Journal, guiding scholarly communication in the field while maintaining active involvement with the Drug Safety Research Unit as a trustee. Having delivered over 1,200 international lectures worldwide, he has mentored generations of cardiologists and continues to advance the specialty through his work on cardiac resynchronization therapy and ventricular repolarization. His enduring legacy encompasses both the scientific understanding of cardiac arrhythmias and the practical implementation of life-saving treatments that have improved outcomes for patients across the globe.
